This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Turning Point Brands (TPB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Turning Point Brands (TPB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Consider Buying Altria Stock Before Q3 Earnings Release?
by Vrishali Bagree
MO's Q3 results are likely to gain strength from pricing power, cost discipline and growing smoke-free momentum.
MO Optimize & Accelerate Initiative: Enough to Boost Long-Term EPS?
by Zacks Equity Research
Altria's Optimize & Accelerate program reinvests cost savings to fuel smoke-free growth and long-term EPS.
Philip Morris (PM) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of +6.67% and +1.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Altria Rises 12% in 3 Months: Should You Buy, Sell or Hold the Stock?
by Swati Prasad
MO's 12% 3-month surge highlights strong earnings, rising smoke-free sales and disciplined execution amid industry weakness.
Altria's Oral Margins Surge to 68.7%: Can the Strength Last?
by Zacks Equity Research
MO's oral segment OCI margin hits 68.7% as on! pouches boost profitability despite volume dips and rising competition.
Zacks Industry Outlook Highlights Philip Morris International, Altria and Turning Point Brands
by Zacks Equity Research
Despite declining cigarette sales, Philip Morris International, Altria, and Turning Point Brands are driving growth through smoke-free innovations and shifting consumer trends.
3 Tobacco Stocks to Keep an Eye on Amid Industry Challenges
by Swati Prasad
PM, MO and TPB are navigating declining cigarette sales and rising health awareness through smoke-free innovations and strategic portfolio expansion.
MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?
by Zacks Equity Research
Altria's on! nicotine pouch brand captures 8.7% of the U.S. oral tobacco market, fueling growth and brand momentum in a fierce competitive landscape.
Altria Delivers 7.2% EPS Growth in 1H25 Despite Sales Headwinds
by Zacks Equity Research
MO's first half of 2025 EPS grows 7.2% to $2.67 despite revenue declines, as pricing, efficiency gains and buybacks lifted margins and returns.